Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1936 to 1950 of 8236 results

  1. Niraparib with abiraterone acetate and prednisone for treating hormone-sensitive metastatic prostate cancer [ID6595]

    Awaiting development Reference number: GID-TA11558 Expected publication date: TBC

  2. Alcohol Use Disorders (update)

    In development Reference number: GID-NG10445 Expected publication date: TBC

  3. Budesonide (Jorveza) for maintaining remission of eosinophilic oesophagitis in people 2 years and over [ID6486]

    Awaiting development Reference number: GID-TA11623 Expected publication date: TBC

  4. Cyanoacrylate glue for hernia mesh fixation (MT707)

    Topic prioritisation

  5. O2Matic pro 100 (MT746)

    Topic prioritisation

  6. Subcutaneous pembrolizumab with platinum-based chemotherapy for untreated metastatic non-small-cell lung cancer [TSID12213]

    Topic prioritisation

  7. Oral cabotegravir with rilpivirine for treating HIV-1 in people 12 to 17 years [TSID12214]

    Topic prioritisation

  8. Long-acting injections of cabotegravir with rilpivirine for treating HIV-1 in people 12 to 17 years [TSID12219]

    Topic prioritisation

  9. MT684 Smart Peak Flow for monitoring asthma

    Topic prioritisation

  10. The Insides System chyme reinfusion system (MT682)

    Topic prioritisation

  11. TUC Safety Valve to prevent balloon inflation in the urethra during transurethral catheterisation (MT512)

    Topic prioritisation

  12. Lumella Pre-Eclampsia point-of-care test for assessing pre-eclampsia risk (MT687)

    Topic prioritisation

  13. RespiraSense (MT736)

    Topic prioritisation

  14. Signatera molecular residual disease assay (MT741)

    Topic prioritisation

  15. Stockholm3 blood test for prostate cancer, (MT734),

    Topic prioritisation